全文获取类型
收费全文 | 1045篇 |
免费 | 135篇 |
专业分类
1180篇 |
出版年
2021年 | 13篇 |
2020年 | 8篇 |
2018年 | 7篇 |
2016年 | 13篇 |
2015年 | 18篇 |
2014年 | 36篇 |
2013年 | 35篇 |
2012年 | 58篇 |
2011年 | 47篇 |
2010年 | 38篇 |
2009年 | 23篇 |
2008年 | 25篇 |
2007年 | 25篇 |
2006年 | 33篇 |
2005年 | 41篇 |
2004年 | 32篇 |
2003年 | 27篇 |
2002年 | 26篇 |
2001年 | 26篇 |
2000年 | 29篇 |
1999年 | 35篇 |
1998年 | 18篇 |
1997年 | 14篇 |
1996年 | 18篇 |
1995年 | 16篇 |
1994年 | 11篇 |
1993年 | 17篇 |
1992年 | 26篇 |
1991年 | 24篇 |
1990年 | 28篇 |
1989年 | 23篇 |
1988年 | 17篇 |
1987年 | 19篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 22篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 7篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1976年 | 15篇 |
1973年 | 11篇 |
1972年 | 13篇 |
1971年 | 7篇 |
1970年 | 8篇 |
1969年 | 11篇 |
1888年 | 7篇 |
排序方式: 共有1180条查询结果,搜索用时 15 毫秒
901.
902.
N. Steen A. Hutchinson E. McColl M. P. Eccles J. Hewison K. A. Meadows S. M. Blades P. Fowler 《BMJ (Clinical research ed.)》1994,309(6961):1065-1068
Measuring symptom specific health outcome is complex, but the methodologies now exist to develop measures with the appropriate properties. As one element of a major programme to develop multidomain health outcome measures for chronic disease, a symptom based measure for asthma care has been developed for use in general practice and outpatient departments. This article outlines the development process, which used a framework recently described in the theoretical literature to show the constraints that scientific criteria place on the development of outcome measures and the means of overcoming such limiting factors. Although substantial effort is required to undertake a rigorous process of development, useful tools are the result. Two five item, symptom based outcome measures for adult asthma are described. 相似文献
903.
904.
905.
Doube M Klosowski MM Wiktorowicz-Conroy AM Hutchinson JR Shefelbine SJ 《Proceedings. Biological sciences / The Royal Society》2011,278(1721):3067-3073
Many bones are supported internally by a latticework of trabeculae. Scaling of whole bone length and diameter has been extensively investigated, but scaling of the trabecular network is not well characterized. We analysed trabecular geometry in the femora of 90 terrestrial mammalian and avian species with body masses ranging from 3 g to 3400 kg. We found that bone volume fraction does not scale substantially with animal size, while trabeculae in larger animals' femora are thicker, further apart and fewer per unit volume than in smaller animals. Finite element modelling indicates that trabecular scaling does not alter the bulk stiffness of trabecular bone, but does alter strain within trabeculae under equal applied loads. Allometry of bone's trabecular tissue may contribute to the skeleton's ability to withstand load, without incurring the physiological or mechanical costs of increasing bone mass. 相似文献
906.
Marije B Overdijk Sandra Verploegen Marijn B?gels Marjolein van Egmond Jeroen J Lammerts van Bueren Tuna Mutis Richard WJ Groen Esther Breij Anton CM Martens Wim K Bleeker Paul WHI Parren 《MABS-AUSTIN》2015,7(2):311-320
Daratumumab (DARA) is a human CD38-specific IgG1 antibody that is in clinical development for the treatment of multiple myeloma (MM). The potential for IgG1 antibodies to induce macrophage-mediated phagocytosis, in combination with the known presence of macrophages in the tumor microenvironment in MM and other hematological tumors, led us to investigate the contribution of antibody-dependent, macrophage-mediated phagocytosis to DARA''s mechanism of action. Live cell imaging revealed that DARA efficiently induced macrophage-mediated phagocytosis, in which individual macrophages rapidly and sequentially engulfed multiple tumor cells. DARA-dependent phagocytosis by mouse and human macrophages was also observed in an in vitro flow cytometry assay, using a range of MM and Burkitt''s lymphoma cell lines. Phagocytosis contributed to DARA''s anti-tumor activity in vivo, in both a subcutaneous and an intravenous leukemic xenograft mouse model. Finally, DARA was shown to induce macrophage-mediated phagocytosis of MM cells isolated from 11 of 12 MM patients that showed variable levels of CD38 expression. In summary, we demonstrate that phagocytosis is a fast, potent and clinically relevant mechanism of action that may contribute to the therapeutic activity of DARA in multiple myeloma and potentially other hematological tumors. 相似文献
907.
Nan Zhong Peter Loppnau Alma Seitova Mani Ravichandran Maria Fenner Harshika Jain Anandi Bhattacharya Ashley Hutchinson Marcin Paduch Vincent Lu Michal Olszewski Anthony A. Kossiakoff Evan Dowdell Akiko Koide Shohei Koide Haiming Huang Vincent Nadeem Sachdev S. Sidhu Jack F. Greenblatt Edyta Marcon Cheryl H. Arrowsmith Aled M. Edwards Susanne Gr?slund 《PloS one》2015,10(10)
We developed and optimized a high-throughput project workflow to generate renewable recombinant antibodies to human proteins involved in epigenetic signalling. Three different strategies to produce phage display compatible protein antigens in bacterial systems were compared, and we found that in vivo biotinylation through the use of an Avi tag was the most productive method. Phage display selections were performed on 265 in vivo biotinylated antigen domains. High-affinity Fabs (<20nM) were obtained for 196. We constructed and optimized a new expression vector to produce in vivo biotinylated Fabs in E. coli. This increased average yields up to 10-fold, with an average yield of 4 mg/L. For 118 antigens, we identified Fabs that could immunoprecipitate their full-length endogenous targets from mammalian cell lysates. One Fab for each antigen was converted to a recombinant IgG and produced in mammalian cells, with an average yield of 15 mg/L. In summary, we have optimized each step of the pipeline to produce recombinant antibodies, significantly increasing both efficiency and yield, and also showed that these Fabs and IgGs can be generally useful for chromatin immunoprecipitation (ChIP) protocols. 相似文献
908.
Jessica AB van Nies Celina Alves Audrey LS Radix-Bloemen Cécile Gaujoux-Viala Tom WJ Huizinga Johanna MW Hazes Elisabeth Brouwer Bruno Fautrel Annette HM van der Helm-van Mil 《Arthritis research & therapy》2015,17(1)
IntroductionMorning stiffness is assessed daily in the diagnostic process of arthralgia and arthritis, but large-scale studies on the discriminative ability are absent. This study explored the diagnostic value of morning stiffness in 5,202 arthralgia and arthritis patients and the prognostic value in early rheumatoid arthritis (RA).MethodsIn arthralgia patients referred to the Early Arthritis Recognition Clinics (EARC) of Leiden (n = 807) and Groningen (n = 481) or included in the Rotterdam Early Arthritis Cohort (REACH) study (n = 353), the associations (cross-sectional analyses) between morning stiffness and presence of arthritis at physical examination were studied. In early arthritis patients, included in the Leiden Early Arthritis Clinic (EAC) (n = 2,748) and Evaluation et Suivi de POlyarthrites Indifférenciées Récentes (ESPOIR) (n = 813), associations with fulfilling the 2010-RA criteria after one year were assessed. In 2010-RA patients included in the EAC (n = 1,140) and ESPOIR (n = 677), association with the long-term outcomes of disease-modifying antirheumatic drug (DMARD)-free sustained remission and radiological progression were determined. Morning stiffness was defined as a duration ≥60 minutes; sensitivity analyses were performed for other definitions.ResultsIn arthralgia, morning stiffness (≥60 minutes) associated with the presence of arthritis; Leiden EARC odds ratio (OR) 1.49 (95% CI 1.001 to 2.20), Groningen EARC OR 2.21 (1.33 to 3.69) and REACH OR 1.55 (0.97 to 2.47) but the areas under the receiver operating characteristic curve (AUCs) were low (0.52, 0.57, 0.54). In early arthritis, morning stiffness was associated with 2010-RA independent of other predictors (Leiden EAC OR 1.72 (95% CI 1.31 to 2.25, AUC 0.68), ESPOIR OR 1.68 (1.03 to 2.74, AUC 0.64)). Duration of ≥30 minutes provided optimal discrimination for RA in early arthritis. Morning stiffness was not associated with radiological progression or DMARD-free sustained remission.ConclusionsMorning stiffness in arthralgia and early arthritis is associated with arthritis and RA respectively. This supports the incorporation of morning stiffness in the diagnostic process.
Electronic supplementary material
The online version of this article (doi:10.1186/s13075-015-0616-3) contains supplementary material, which is available to authorized users. 相似文献909.
Reed Cody C. Merrill Amy G. Drew W. Mark Christman Beth Hutchinson Rachel A. Keszey Levi Odell Melissa Swanson Sherman Verburg Paul S. J. Wilcox Jim Hart Stephen C. Sullivan Benjamin W. 《Ecosystems》2021,24(5):1125-1141
Ecosystems - As the largest biogeochemically active terrestrial reserve of carbon (C), soils have the potential to either mitigate or amplify rates of climate change. Ecosystems with large C stocks... 相似文献
910.
Ellis RP Parry H Spicer JI Hutchinson TH Pipe RK Widdicombe S 《Fish & shellfish immunology》2011,30(6):1209-1222
The inception of ecological immunology has led to an increase in the number of studies investigating the impact of environmental stressors on host immune defence mechanisms. This in turn has led to an increased understanding of the importance of invertebrate groups for immunological research. This review discusses the advances made within marine invertebrate ecological immunology over the past decade. By demonstrating the environmental stressors tested, the immune parameters typically investigated, and the species that have received the greatest level of investigation, this review provides a critical assessment of the field of marine invertebrate ecological immunology. In highlighting the methodologies employed within this field, our current inability to understand the true ecological significance of any immune dysfunction caused by environmental stressors is outlined. Additionally, a number of examples are provided in which studies successfully demonstrate a measure of immunocompetence through alterations in disease resistance and organism survival to a realized pathogenic threat. Consequently, this review highlights the potential to advance our current understanding of the ecological and evolutionary significance of environmental stressor related immune dysfunction. Furthermore, the potential for the advancement of our understanding of the immune system of marine invertebrates, through the incorporation of newly emerging and novel molecular techniques, is emphasized. 相似文献